hBD-1 vs Bremelanotide
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Bremelanotide (Bremelanotide (PT-141), cyclic melanocortin receptor agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | Bremelanotide |
|---|---|---|
| Category | Dental & Oral | Sexual Health |
| Full Name | Human beta-defensin 1 | Bremelanotide (PT-141), cyclic melanocortin receptor agonist |
| Molecular Weight | 4490 Da | 1025.2 Da |
| Half-Life | minutes to hours | about 2.7 h |
| Amino Acids | 36 | 7 |
| Typical Dose | 1-10 µg/mL in experimental studies | 1.75 mg |
| Route | Topical/Intraoral | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 200 |
| Research Status | Pre-clinical | Clinical |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Bremelanotide Benefits
- ✓increases sexual desire
- ✓supports arousal
- ✓may improve erectile response
- ✓on-demand use
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Bremelanotide Dosing
1.75 mg subcutaneous PRN|administer about 45 minutes before activity|max 1 dose per 24 hours
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Bremelanotide Side Effects
- ⚠nausea
- ⚠flushing
- ⚠headache
- ⚠transient blood pressure increase
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Bremelanotide
Human studies and approval data support meaningful effects on sexual desire in women, with a central mechanism involving melanocortin signaling. It is one of the most clinically relevant peptides in this category and is commonly used as the reference compound for PT-141-type research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.